Monopar Therapeutics — Institutional Ownership

Which tracked institutions hold MNPR, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

19
Funds holding
$132964577
Total value held
Buying
12 added/new · 7 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Janus Henderson Group Plc $72062327 1317410 +1317410 NEW BUY
2 Blackrock, Inc. $32297151 348819 +32252 +10.19%
3 State Street Corp $8569297 92551 +4196 +4.75%
4 Bank Of New York Mellon Corp $7124057 76942 -1676 -2.13%
5 Northern Trust Corp $3207411 34641 +2779 +8.72%
6 Ubs Group Ag $2523911 27259 +27259 NEW BUY
7 Morgan Stanley $1659121 17919 -4393 -19.69%
8 Ameriprise Financial Inc $1648102 17800 +17800 NEW BUY
9 Goldman Sachs Group Inc $1496347 16161 -18549 -53.44%
10 Barclays Plc $540077 5833 -19102 -76.61%
11 Raymond James Financial Inc $506838 5474 +5474 NEW BUY
12 Wells Fargo & Company/Mn $366471 3958 +2230 +129.05%
13 Bank Of America Corp /De/ $300918 3250 -56449 -94.56%
14 Jpmorgan Chase & Co $236967 2506 +84 +3.47%
15 Invesco Ltd. $218142 2356 +2356 NEW BUY
16 Citigroup Inc $193328 2088 -11752 -84.91%
17 Royal Bank Of Canada $13000 136 +87 +177.55%
18 Us Bancorp \De\ $556 6 -66 -91.67%
19 Pnc Financial Services Group, Inc. $556 6 +6 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.